v-src Activation of the collagenase-1 (matrix metalloproteinase-1) promoter through PEA3 and STAT: Requirement of extracellular signal-regulated kinases and inhibition by retinoic acid receptors

Molecular Carcinogenesis

Volumn 21, Issue 3, 1998, Pages 194-204

  Vincenti, Matthew P ^a   Schroen, Daniel J ^a   Coon, Charles I ^a   Brinckerhoff, Constance E ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Mitogen activated protein kinase; Protein kinase C; Retinoids; Signal transduction; Tyrosine kinase

Indexed keywords

COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RETINOIC ACID RECEPTOR;

ANIMAL CELL; ARTICLE; CANCER INVASION; DEGRADATION; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RABBIT; SIGNAL TRANSDUCTION; SYNOVIUM; TRANSCRIPTION REGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; COLLAGENASES; CONSENSUS SEQUENCE; DOWN-REGULATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, SRC; MATRIX METALLOPROTEINASE 1; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RABBITS; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRETINOIN;

ANIMALIA; ORYCTOLAGUS CUNICULUS; POLYOMAVIRUS;

EID: 0031965888     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199803)21:3<194::AID-MC7>3.0.CO;2-M     Document Type: Article

References (64)

1. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7(5):728-735, 1995.
2. Vincenti MP, White LA, Schroen DJ, Benbow U, Brinckerhoff CE. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): Mechanisms that control enzyme activity, transcription and mRNA stability. Crit Rev Eukaryot Gene Expr 6(4):391-411, 1996.
3. Brown PD, Levy AT, Margulies IM, Liotta LA, Stetler-Stevenson WG. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50(19):6184-6191, 1990.
4. Terada T, Okada Y, Nakanuma Y. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors. Hepatology 23(6):1341-1344, 1996.
5. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149(1):273-282, 1996.
6. Hansell EJ, Frisch SM, Tremble P, Murnane JP, Werb Z. Simian virus 40 transformation alters the actin cytoskeleton, expression of matrix metalloproteinases and inhibitors of metalloproteinases, and invasive behavior of normal and ataxia-telangiectasia human skin fibroblasts. Biochem Cell Biol 73(7-8):373-389, 1995.
7. D'Armiento J, DiColandrea T, Dalal SS, et al. Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol Cell Biol 15(10):5732-5739, 1995.
8. Courtneidge SA, Fumagalli S, Koegl M, Superti-Furga G, Twamley-Stein GM. The Src family of protein tyrosine kinases: Regulation and functions. Dev Suppl:57-64, 1993.
9. Kaplan KB, Bibbins KB, Swedlow JR, Arnaud M, Morgan DO, Varmus HE. Association of the amino-terminal half of c-Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527. EMBO J 13(20):4745-4756, 1994.
10. Luttrell DK, Lee A, Lansing TJ, et al. Involvement of pp60c-src with two major signaling pathways in human breast cancer. Proc Natl Acad Sci USA 91(1):83-87, 1994.
11. Muthuswamy SK, Muller WJ. Activation of the Src family of tyrosine kinases in mammary tumorigenesis. Adv Cancer Res 64:111-123, 1994.
12. Cartwright CA, Meisler AI, Eckhart W. Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis. Proc Natl Acad Sci USA 87(2):558-562, 1990.
13. Yamamoto T, Akiyama T, Semba K, et al. Oncogenic potential and normal function of the proto-oncogenes encoding protein-tyrosine kinases. In: Kuroda Y, Shankel D, Waters M (ed), Oncogenic Potential and Normal Function of the Proto-oncogenes Encoding Protein-Tyrosine Kinases, Vol 52. Plenum Press, New York, 1990, pp. 321-339.
14. Vincenti MP, Coon CI, White LA, Barchowsky A, Brinckerhoff CE. src-related tyrosine kinases regulate transcriptional activation of the interstitial collagenase gene, MMP-1, in interleukin-1-stimulated synovial fibroblasts. Arthritis Rheum 39(4):574-582, 1996.
15. Gutman A, Wasylyk B. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 9(7):2241-2246, 1990.
16. Gupta SK, Gallego C, Johnson GL, Heasley LE. MAP kinase is constitutively activated in gip2 and src transformed rat 1a fibroblasts. J Biol Chem 267(12):7987-7990, 1992.
17. Derijard B, Hibi M, Wu I-H, et al. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-jun activation domain. Cell 76:1025-1037, 1994.
18. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. Cell 270(28):16483-16486, 1995.
19. Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403-407, 1995.
20. L'Allemain G, Pouyssegur J, Weber MJ. p42/mitogen-activated protein kinase as a converging target for different growth factor signaling pathways: Use of pertussis toxin as a discrimination factor. Cell Regulation 2(8):675-684, 1991.
21. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331, 1995.
22. Sluss HK, Barrett T, Derijard B, Davis RJ. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol Cell Biol 14(12):8376-8383, 1994.
23. Troppmair J, Bruder JT, Munoz H, et al. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation. J Biol Chem 269(9):7030-7035, 1994.
24. Xie W, Herschmann HR. V-src induces prostaglandin synthase 2 gene expression by activation of the c-jun N-terminal kinase and c-jun transcription factor. J Biol Chem 270:27622-27628, 1995.
25. Auble DT, Brinckerhoff CE. The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. Biochemistry 30(18):4629-4635, 1991.
26. White LA, Brinckerhoff CE. Two AP-1 elements in the collagenase promoter have differential effects on transcription and bind JunD, c-Fos, and Fra-2. Matrix Biol 14:715-725, 1995.
27. Dehbi M, Mbiguino A, Beauchemin M, Chatelain G, Bedard PA. Transcriptional activation of the CEF-4/9E3 cytokine gene by pp60v-src. Mol Cell Biol 12(4):1490-1499, 1992.
28. Lotan R. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers. Anticancer Res 16(4C):2415-2419, 1996.
29. Jetten AM, Barrett JC, Gilmer TM. Differential response to retinoic acid of syrian hamster embryo fibroblasts expressing v-src, or v-Ha-ras oncogenes. Mol Cell Biol 6(10):3341-3348, 1986.
30. Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB J 10:1002-1013, 1996.
31. Lafyatis R, Kim SJ, Angel P, et al. Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5′ activator protein-1-binding site. Mol Endocrinol 4(7):973-980, 1990.
32. Pan L-Y, Chamberlain SH, Auble DT, Brinckerhoff CE. Differential regulation of collagenase gene expression by retinoic acid receptors-alpha, beta, and gamma. Nucleic Acids Res 20:3105-3111, 1992.
33. Pan L, Eckhoff C, Brinckerhoff CE. Suppression of collagenase gene expression by all-trans and 9-cis retinoic acid is ligand dependent and requires both RARs and RXRs. J Cell Biochem 57:575-589, 1995.
34. Schroen DJ, Brinckerhoff CE. Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms. Gene Expr 6:197-207, 1996.
35. Schroen DJ, Brinckerhoff CE. Inhibition of rabbit collagenase (matrix metalloproteinase-1; MMP-1) transcription by retinoic acid receptors: Evidence for binding of RARs/RXRs to the -77 AP-1 site through interactions with c-jun. J Cell Physiol 169(2):320-332, 1996.
36. Nicholson RC, Mader S, Nagpal S, Leid M, Rochette-Egly C, Chambon P. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. EMBO J 9(13):4443-4454, 1990.
37. Gross RH, Sheldon LS, Flether CF, Brinckerhoff CE. Isolation of a collagenase cDNA clone and measurement of changing collagenase mRNA levels during induction in rabbit synovial fibroblasts. Proc Natl Acad Sci USA 81:1981-1985, 1984.
38. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59, 1989.
39. Minden A, Lin A, Claret F-X, Abo A, Karin M. Selective activation of the JNK signaling cascade and c-jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81:1147-1157, 1995.
40. Vincenti MP, Clark IM, Brinckerhoff CE. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? Arthritis Rheum 37(8):1115-1126, 1994.
41. Chamberlain SH, Hemmer RM, Brinckerhoff CE. Novel phorbol ester response region in the collagenase promoter binds Fos and Jun. J Cell Biochem 52(3):337-351, 1993.
42. Kenny S, Guntaka RV. Localization by mutational analysis of transcription factor binding sequences in the U3 region of rous sarcoma virus LTR. Virology 176:483-493, 1990.
43. Wasylyk C, Gutman A, Nicholson R, Wasylyk B. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J 10(5):1127-1134, 1991.
44. Vincenti MP, Coon CI, Lee O, Brinckerhoff CE. Regulation of collagenase gene expression by IL-1 beta requires transcriptional and post-transcriptional mechanisms. Nucleic Acids Res 22(22);4818-4827, 1994.
45. Williams TM, Burlein JE, Ogden S, Kricka LJ, Kant JA. Advantages of firefly luciferase as a reporter gene: Application to the interleukin-2 gene promoter. Anal Biochem 176:28-32, 1989.
46. Korzus E, Nagase H, Rydell R, Travis J. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J Biol Chem 272(2):1188-1196, 1997.
47. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 10(9):940-954, 1996.
48. Sporn MB, Roberts AB, Goodman DG. The Retinoids: Biology, Chemistry and Medicine. Raven Press, New York, 1994.
49. Chen JD, Umesono K, Evans RM. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc Natl Acad Sci USA 93(15):7567-7571, 1996.
50. Chen JD, Evans RM. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377(6548):454-457, 1995.
51. Horlein AJ, Naar AM, Heinzel T, et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377(6548):397-404, 1995.
52. Schroen DJ, Chen JD, Vincenti MP, Brinckerhoff CE. The nuclear receptor co-repressor SMRT inhibits interstitial collagenase (MMP-1) transcription through an HRE-independent mechanism. Biochem Biophys Res Commun 237:52-58, 1997.
53. Birchenall-Roberts MC, Ruscetti FW, Kasper J, et al. Transcriptional regulation of the transforming growth factor beta 1 promoter by v-src gene products is mediated through the AP-1 complex. Mol Cell Biol 10(9):4978-4983, 1990.
54. Xie W, Fletcher BS, Andersen RD, Herschman HR. v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element. Mol Cell Biol 14(10):6531-6539, 1994.
55. Sato H, Kita M, Seiki M. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J Biol Chem 268(31):23460-23468, 1993.
56. Cao X, Tay A, Guy GR, Tan YH. Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol Cell Biol 16(4):1595-1603, 1996.
57. Campbell GS, Yu CL, Jove R, Carter-Su C. Constitutive activation of JAK1 in Src-transformed cells. J Biol Chem 272(5):2591-2594, 1997.
58. Zang Q, Frankel P, Foster DA. Selective activation of protein kinase C isoforms by v-Src. Cell Growth Differ 6(11):1367-1373, 1995.
59. Song J, Foster DA. v-Src activates a unique phospholipase D activity that can be distinguished from the phospholipase D activity activated by phorbol esters. Biochem J 294(Pt 3):711-717, 1993.
60. Devary Y, Gottlieb RA, Smeal T, Karin M. The mammalian ultraviolet response is triggered by activation of src tyrosine kinases. Cell 71:1081-1091, 1992.
61. Frost JA, Geppert TD, Cobb MH, Feramisco JR. A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate and serum. Proc Natl Acad Sci USA 91:3844-3848, 1994.
62. Lotan R, Xu X-C, Lippman SM, et al. Suppression of retinoic acid receptor β in oral premalignant lesions and its upregulation by isotretinoin. N Eng J Med 332:1405-1410, 1995.
63. Darwiche N, Celli G, Tennenbaum T, Glick AB, Yuspa SH, Deluca LM. Mouse skin tumor progression results in differential expression of retinoic acid and retinoic X receptors. Cancer Res 55:2774-2782, 1995.
64. Rutter JL, Benbow U, Coon CI, Brinckerhoff CE. Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1β (IL-1β) in human fibroblasts and BC-8701 breast cancer cells. J Cell Biochem 66:322-336, 1997.